Cargando…
Survival after radiofrequency ablation and/or chemotherapy for lung cancer and pulmonary metastases: a systematic review and meta-analysis
BACKGROUND: Radiofrequency ablation (RFA) and chemotherapy are used to treat lung cancer or pulmonary metastases, but no direct comparison of overall survival (OS) has been published. The present study aimed to assess the OS of RFA and/or chemotherapy in patients with lung cancer or pulmonary metast...
Autores principales: | Yang, Ziyi, Lyu, Xia, Yang, Huilin, Wang, Bingbing, Xu, Dan, Huo, Lingyi, Zhang, Runzi, Huang, Yingjun, Diao, Benshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587578/ https://www.ncbi.nlm.nih.gov/pubmed/37869011 http://dx.doi.org/10.3389/fimmu.2023.1240149 |
Ejemplares similares
-
Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases?
por: Govaert, Klaas M., et al.
Publicado: (2012) -
A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
por: Löffler, Markus W., et al.
Publicado: (2019) -
Long-Term Survival of Two Patients with Liver Metastases from Advanced Gastric Cancer Treated with Radiofrequency Ablation and Chemotherapy
por: Oh, Sung Jin
Publicado: (2021) -
Survival Evidence of Local Control for Colorectal Cancer Liver Metastases by Hepatectomy and/or Radiofrequency Ablation
por: Canseco, Lariza Marie, et al.
Publicado: (2023) -
Microwave ablation versus radiofrequency ablation for treating spinal metastases
por: Yao, Yuming, et al.
Publicado: (2023)